Assessment of the Pharmaceutical Situation in Kenya - A Baseline Survey: 4. RESULTS AND ANALYSIS: 4.2 LEVEL II CORE INDICATORS: 4.2.3 RATIONAL USE: 4.2.3.7 Percentage availability of STG and EDL at public health facilities

Home page | Help | Clear

English | French

Full TOC

Expand Document

Expand Chapter

Preferences

Printable HTML version

Export document as HTML file Help

Abbreviations


Assessment of the Pharmaceutical Situation in Kenya - A Baseline Survey (HAI, WHO; 2003; 78 pages)
	LIST OF ABBREVIATIONS
	ACKNOWLEDGEMENTS
	1. EXECUTIVE SUMMARY
	2. INTRODUCTION
		2.1 COUNTRY PROFILE
		2.2 STRUCTURE OF HEALTH AND PHARMACEUTICAL SYSTEMS
		2.3 NATIONAL MEDICINES POLICY
		2.4 MEDICINE PRODUCTION
	3. SURVEY DESIGN AND METHODOLOGY
		3.1 SURVEY PURPOSE
		3.2 METHODOLOGY
	4. RESULTS AND ANALYSIS
		4.1 LEVEL I CORE INDICATORS
			4.1.1 National Medicine Policy
			4.1.2 Legislation/regulation
			4.1.3 Quality control of pharmaceuticals
			4.1.4 Essential medicines list
			4.1.5 Medicines supply system
			4.1.6 Medicines financing
			4.1.7 Access to essential medicines
			4.1.8 Production
			4.1.9 Rational use
		4.2 LEVEL II CORE INDICATORS
			4.2.1 ACCESS
				4.2.1.1 Availability of key medicines in public health facilities, regional warehouses and private pharmacies
				4.2.1.2 Adequacy* of stock records in public health facilities and regional warehouses
				4.2.1.3 Affordability of treatment at public health facilities and private pharmacies
				4.2.1.4 Percentage of prescribed medicines actually dispensed or administered to patients in Public health facilities
				4.2.1.5 Access to medicines by households
			4.2.2 QUALITY AND SAFETY
				4.2.2.1 Presence of expired medicines in public health facility pharmacies, regional warehouses and Private pharmacy outlets
				4.2.2.2 Adequacy* of Conservation conditions and handling of medicines in public health facility and regional warehouses
			4.2.3 RATIONAL USE
				4.2.3.1 Adequacy* of labeling of medicines dispensed by public health facility pharmacies
				4.2.3.2 Percentage of patients at public health facilities who know how to take medicines
				4.2.3.3 Average number of medicines prescribed in public health facilities
				4.2.3.4 Percentage of patients at public health facilities receiving antibiotics
				4.2.3.5 Percentage of patients prescribed an injection in public health facilities
				4.2.3.6 Percentage of medicines prescribed at public health facilities on EDL
				4.2.3.7 Percentage availability of STG and EDL at public health facilities
				4.2.3.8 Medicine prescribing by INN/generic name
				4.2.3.9 Percentage of tracer cases at public health facilities treated with medicines recommended or discouraged in STGs.
				4.2.3.10 Use of medicines by households
	5. CONCLUSION
	6. POSITIVE ASPECTS AND AREAS FOR IMPROVEMENT IDENTIFIED
	7. SUMMARY OF RECOMMENDATIONS
	APPENDICES
		APPENDIX 1 - PROPOSAL
		APPENDIX 2 - TRAINING TIMETABLE
		APPENDIX 3 - ALLOCATION OF HEALTH FACILITIES TO DATA COLLECTORS
		APPENDIX 4 - SURVEY FORMS 1-16
		APPENDIX 5 - LIST OF 15 BASKET OF MEDICINES
		APPENDIX 6 - COMPLETED LEVEL ONE QUESTIONNAIRE

4.2.3.7 Percentage availability of STG and EDL at public health facilities

• Standard treatment guidelines were found in 13% of public health facilities and the essential drugs list in 17% of the facilities.

• However the median percentage of medicines prescribed that were on the EDL was found to be 81%. The high adherence to prescribing according to EDL compared to the low availability of EDL in public health facilities is probably because the range of medicines procured and supplied to these facilities is within the EDL and generally only those medicines are available.

Figure 4.18 Percent availability of STGs and EDL in public health facilities.

Please provide your feedback

Abbreviations

English | French